The murine glucagon-like peptide-1 receptor is essential for control of bone resorption

Endocrinology

Volumn 149, Issue 2, 2008, Pages 574-579

  Yamada, Chizumi ^a   Yamada, Yuichiro ^a,c   Tsukiyama, Katsushi ^a,h   Yamada, Kotaro ^a   Udagawa, Nobuyuki ^d   Takahashi, Naoyuki ^d   Tanaka, Kiyoshi ^e   Drucker, Daniel J ^f   Seino, Yutaka ^a,g   Inagaki, Nobuya ^a,b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d MATSUMOTO DENTAL UNIVERSITY   (Japan)

^e KYOTO WOMEN'S UNIVERSITY   (Japan)

^f MOUNT SINAI HOSPITAL   (Canada)

^g KANSAI ELECTRIC POWER CO   (Japan)

^h ANJO KOSEI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCIUM; DEOXYPYRIDINOLINE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; PARATHYROID HORMONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DENSITOMETRY; BONE FRAGILITY; BONE METABOLISM; CELL ACTIVATION; CELL COUNT; CHEMICAL ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION; KNOCKOUT MOUSE; MALE; METABOLIC REGULATION; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; RNA ANALYSIS; THYROID GLAND; WILD TYPE;

ABSORPTIOMETRY, PHOTON; ANIMALS; BONE RESORPTION; CALCITONIN; CALCIUM; GLUCAGON-LIKE PEPTIDE 1; HYPOGLYCEMIC AGENTS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCLASTS; PEPTIDES; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION; TIBIA; VENOMS;

EID: 38549146030     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1292     Document Type: Article

References (33)

1. Henriksen DB, Alexandersen P, Bjarnason NH, Vilsboll T, Hartmann B, Henriksen EE, Byrjalsen I, Krarup T, Holst JJ, Christiansen C 2003 Role of gastrointestinal hormones in postprandial reduction of bone resorption. J Bone Miner Res 18:2180-2189
2. Tsukiyama K, Yamada Y, Yamada C, Harada N, Kawasaki Y, Ogura M, Bessho K, Li M, Amizuka N, Sato M, Udagawa N, Takahashi N, Tanaka K, Oiso Y, Seino Y 2006 Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. Mol Endocrinol 20:1644-1651
3. Bollag RJ, Zhong Q, Phillips P, Min L, Zhong L, Cameron R, Mulloy AL, Rasmussen H, Qin F, Ding KH, Isales CM 2000 Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology 141:1228-1235
4. Zhong Q, Itokawa T, Sridhar S, Ding KH, Xie D, Kang B, Bollag WB, Bollag RJ, Hamrick M, Insogna K, Isales CM 2007 Effects of glucose-dependent insulinotropic peptide on osteoclast function. Am J Physiol Endocrinol Metab 292:E543-E548
5. Xie D, Cheng H, Hamrick M, Zhong Q, Ding KH, Correa D, Williams S, Mulloy A, Bollag W, Bollag RJ, Runner RR, McPherson JC, Insogna K, Isales CM 2005 Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover. Bone 37:759-769
6. Xie D, Zhong Q, Ding KH, Cheng H, Williams S, Correa D, Bollag WB, Bollag RJ, Insogna K, Troiano N, Coady C, Hamrick M, Isales CM 2007 Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass. Bone 40:1352-1360
7. Henriksen DB, Alexandersen P, Byrjalsen I, Hartmann B, Bone HG, Christiansen C, Holst JJ 2004 Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2. Bone 34:140-147
8. Henriksen DB, Alexandersen P, Hartmann B, Adrian CL, Byrjalsen I, Bone HG, Holst JJ, Christiansen C 2007 Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women. Bone 40:723-729
9. Vilsboll T, Krarup T, Deacon CF, Madsbad S, Holst JJ 2001 Reduced post-prandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50:609-613
10. Crespel A, De Boisvilliers F, Gros L, Kervran A 1996 Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line. Endocrinology 137:3674-3680
11. Lamari Y, Boissard C, Moukhtar MS, Jullienne A, Rosselin G, Garel JM 1996 Expression of glucagon-like peptide 1 receptor in a murine C cell line: regulation of calcitonin gene by glucagon-like peptide 1. FEBS Lett 393:248-252
12. Hansotia T, Baggio LL, Delmeire D, Hinke SA, Yamada Y, Tsukiyama K, Seino Y, Holst JJ, Schuit F, Drucker DJ 2004 Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors. Diabetes 53:1326-1335
13. Yamanouchi K, Yada E, Hozumi H, Ueno C, Nishihara M 2004 Analyses of hind leg skeletons in human growth hormone transgenic rats. Exp Gerontol 39:1179-1188
14. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
15. Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, Shinki T, Gillespie MT, Martin TJ, Higashio K, Suda T 2000 Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141:3478-3484
16. Li X, Udagawa N, Itoh K, Suda K, Murase Y, Nishihara T, Suda T, Takahashi N 2002 p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 143:3105-3113
17. Schwartz AV 2003 Diabetes mellitus: does it affect bone? Calcif Tissue Int 73:515-519
18. Carnevale V, Romagnoli E, D'Erasmo E 2004 Skeletal involvement in patients with diabetes mellitus. Diabetes Metab Res Rev 20:196-204
19. Rakic V, Davis WA, Chubb SA, Islam FM, Prince RL, Davis TM 2006 Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study. Diabetologia 49:863-871
20. Bagi CM, Hanson N, Andresen C, Pero R, Lariviere R, Turner CH, Laib A 2006 The use of micro-CT to evaluate cortical bone geometry and strength in nude rats: correlation with mechanical testing, pQCT and DXA. Bone 38:136-144
21. Christensen J O, Svendsen OL 1999 Bone mineral in pre- and postmenopausal women with insulin-dependent and non-insulin-dependent diabetes mellitus. Osteoporos Int 10:307-311
22. Suzuki K, Sugimoto C, Takizawa M, Ishizuka S, Kikuyama M, Togawa H, Taguchi Y, Nosaka K, Seino Y, Ishida H 2000 Correlations between bone mineral density and circulating bone metabolic markers in diabetic patients. Diabetes Res Clin Pract 48:185-191
23. Majima T, Komatsu Y, Yamada T, Koike Y, Shigemoto M, Takagi C, Hatanaka I, Nakao K 2005 Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients. Osteoporos Int 16:907-913
24. Suzuki K, Kurose T, Takizawa M, Maruyama M, Ushikawa K, Kikuyama M, Sugimoto C, Seino Y, Nagamatsu S, Ishida H 2005 Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density. Diabetes Res Clin Pract 68:117-125
25. Wronski TJ, Yen CF, Burton KW, Mehta RC, Newman PS, Soltis EE, DeLuca PP 1991 Skeletal effects of calcitonin in ovariectomized rats. Endocrinology 129:2246-2250
26. Li M, Shen Y, Burton KW, DeLuca PP, Mehta RC, Baumann BD, Wronski TJ 1996 A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats. Bone 18:375-380
27. Wallach S, Rousseau G, Martin L, Azria M 1999 Effects of calcitonin on animal and in vitro models of skeletal metabolism. Bone 25:509-516
28. Mochizuki K, Inoue T 2000 Effect of salmon calcitonin on experimental osteoporosis induced by ovariectomy and low-calcium diet in the rat. J Bone Miner Metab 18:194-207
29. Mosekilde L, Danielsen CC, Gasser J 1994 The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats. Endocrinology 134:2126-2134
30. Giardino R, Fini M, Aldini NN, Gnudi S, Biagini G, Gandolfi MG, Mongiorgi R 1996 Calcitonin and alendronate effects on bone quality in osteoporotic rats. J Bone Miner Res 21:S335 (Abstract)
31. Huebner AK, Schinke T, Priemel M, Schilling S, Schilling AF, Emeson RB, Rueger JM, Amling M 2006 Calcitonin deficiency in mice progressively results in high bone turnover. J Bone Miner Res 21:1924-1934
32. Schwartz AV, Sellmeyer DE, Vittinghoff E, Palermo L, Lecka-Czernik B, Feingold KR, Strotmeyer ES, Resnick HE, Carbone L, Beamer BA, Park SW, Lane NE, Harris TB, Cummings SR 2006 Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab 91:3349-3354
33. Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill MC, Zinman B, Viberti G 2006 Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355:2427-2443